Neutral
West Pharmaceutical restores operations after cyberattack
West Pharmaceutical Services has successfully restored its operations following a recent cyberattack. The company, based in Exton, Pa., announced the ...
WST
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (2)
Neutral (7)
Bearish (1)
Latest WST News
Neutral
Neutral
West Pharmaceutical Services returns to full operations following cybersecurity attack
West Pharmaceutical Services announced that it has fully restored operations across all its sites after experiencing a cybersecurity attack earlier th...
Neutral
Zacks Research Analysts Raise Earnings Estimates for WST
Zacks Research analysts have increased their Q2 2026 EPS estimates for West Pharmaceutical Services (NYSE:WST) from $1.98 to $2.06 and maintained a "S...
Neutral
Bank Julius Baer & Co. Ltd Zurich Sells 3,072 Shares of West Pharmaceutical Services, Inc. $WST
Bank Julius Baer & Co. Ltd Zurich trimmed its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 26.7% during the 4t...
Neutral
West Pharmaceutical Cyberattack Tests Operational Resilience And Investor Risk Assumptions
West Pharmaceutical Services (NYSE:WST) experienced a significant cyberattack involving data exfiltration and system encryption, leading to a temporar...
Neutral
Ransomware attacks on West Pharmaceutical and Foxconn highlight growing cyber risks to manufacturing sector
Recent ransomware attacks on West Pharmaceutical Services and Foxconn underscore the escalating cyber threats faced by the manufacturing sector, impac...
Bearish
Is West Pharmaceutical Services (WST) Pricing Look Stretched After Strong 1 Year Rally?
West Pharmaceutical Services (WST) stock, currently priced at US$300.68, shows mixed returns but a strong 42.8% gain over the last year. However, valu...
Bullish
West Pharmaceutical Reports Higher First-Quarter Revenue, Earnings
West Pharmaceutical Services Inc. reported strong first-quarter 2026 results with net sales up 21.0% to $844.9 million and diluted earnings per share ...
The Top 5 Analyst Questions From West Pharmaceutical Services’s Q1 Earnings Call
West Pharmaceutical Services exceeded Wall Street's expectations in Q1, driven by strong demand for high-value product (HVP) components and operationa...
Bullish
HB Wealth Management LLC Sells 3,325 Shares of West Pharmaceutical Services, Inc. $WST
HB Wealth Management LLC reduced its stake in West Pharmaceutical Services (NYSE: WST) by 27.3% in the fourth quarter, selling 3,325 shares but still ...
Research WST on:
Ad Space